Bioxytran Announces Dr. Milanova Appointed to Board of Directors
BIOXYTRAN, INC. (OTCQB: BIXT), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19 and other viral causing diseases, is pleased to announce that the appointment of a new independent director, Dr. Radka Milanova, to the company’s Board of Directors.
July 15, 2024